Skip to main content

How Safe Is Anticoagulant Therapy in Older Patients and What Should Be the INR Target?

  • Chapter
Cardiac Arrhythmias 2005

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Go AS, Hyiek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375

    Article  PubMed  CAS  Google Scholar 

  2. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457

    Article  Google Scholar 

  3. Hart RG, Pearce LA, Me Bride R et al, on behalf of the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation. Analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 30:1223–1229

    PubMed  CAS  Google Scholar 

  4. Hart RG, Benavente 0, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492–501

    PubMed  CAS  Google Scholar 

  5. Fuster V, Ryden L et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Am J Cardiol 38:1231–1265

    Article  CAS  Google Scholar 

  6. Singer DE, Albers GW, Dalen JE et al (2004) Antithrombotic therapy in atrial fibrillation. The seventh ACCP conference antithrombotic and thrombolytic therapy. Chest 126:429S–256S

    Article  PubMed  CAS  Google Scholar 

  7. Di Pasquale G, Cere E, Biancoli S et al (2002) Antiplatelet agents for prevention of thromboembolism in atrial fibrillation: when, why, and which one? In: Raviele A (ed) Cardiac Arrhythmias 2001, Springer Verlag Italia, Milan, pp 422–435

    Google Scholar 

  8. Bungard TJ, Ghali WA, Teo KK et al (2000) Why do patient with atrial fibrillation not receive warfarin? Arch Intern Med 160:41–46

    Article  PubMed  CAS  Google Scholar 

  9. Cohen N, Sarafian DA, Alon I et al (2000) Warfarin for stroke prevention still underused in atrial fibrillation. Stroke 31:1217–1222

    PubMed  CAS  Google Scholar 

  10. Frykman V, Beermann B, Ryden L, Rosenqvist M (2001) Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 22:1954–1959

    Article  PubMed  CAS  Google Scholar 

  11. Brophy MT, Snyder KE, Gaehde S et al (2004) Anticoagulant use for atrial fibrillation in the Elderly. J Am Geriatr Soc 52:1151–1156

    Article  PubMed  Google Scholar 

  12. Petersen P, Boysen G, Godtfredsen J et al (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1:175–179

    Article  PubMed  CAS  Google Scholar 

  13. Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II S tudy. Lancet 343:687–691

    Google Scholar 

  14. Sebastian J, Tresch DD (2000) Use of oral anticoagulants in older patients. Drugs Aging 16:409–435

    Article  PubMed  CAS  Google Scholar 

  15. Beyth RJ, Landefeld S (1995) Anticoagulants in older patients: a safety perspective. Drugs Aging 6:45–54

    Article  PubMed  CAS  Google Scholar 

  16. Palareti G, Leali N, Coccheri S et al on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348:423–428

    Article  PubMed  CAS  Google Scholar 

  17. Palareti G, Hirsh J, Legnani C et al (2000) Oral anticoagulation treatment in the elderly: a nested prospective, case-control study. Arch Intern Med 160:470–478

    Article  PubMed  CAS  Google Scholar 

  18. Pengo V, Legnani C, Noventa F, Palareti G, on behalf of the ISCOAT Study Group (2001) Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. Thromb Haemost 85:418–422

    PubMed  CAS  Google Scholar 

  19. Landefeld CS, Goldman L (1989) Major bleeding in outpatients treated with warfarin. Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87:144–152

    Article  PubMed  CAS  Google Scholar 

  20. Wehinger C, Stollberger C, Langer T et al (2001) Evaluation of risk factors for stroke/embolism and of complications due to anticoagulant therapy in atrial fibrillation. Stroke 32:2246–2252

    PubMed  CAS  Google Scholar 

  21. Palareti G, Poggi M, Guazzaloca G et al (1997) Assessment of mental ability in elderly anticoagulated patients: its reduction is associated with a less satisfactory quality of treatment. Blood Coagul Fibrinolysis 8:411–417

    PubMed  CAS  Google Scholar 

  22. Kagansky N, Knobler H, Rimon E et al (2004) Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 164:2044–2050

    Article  PubMed  Google Scholar 

  23. American Geriatrics Society (2002) The use of oral anticoagulants (warfarin) in older people. J Am Geriatr Soc 50:1439–1532

    Article  Google Scholar 

  24. Siguret V, Gouin I, Debray et al (2005) Initiation of warfain therapy in elderly medical patients: a safe accurate regimen. Am J Med 118(2):137–140

    Article  PubMed  CAS  Google Scholar 

  25. Bordin P, Mazzone C, Pandullo C et al (2003) Morbidity and mortality in 229 elderly patients with nonrheumatic atrial fibrillation. A five-year follow-up. Ital Heart J 4(8):537–543

    PubMed  Google Scholar 

  26. Ansell JE, Hirsh J, Dalen J et al (2001) Managing oral anticoagulant therapy. Chest 119: 22S–38S

    Article  PubMed  CAS  Google Scholar 

  27. Chiquette E, Amato MG, Bussey HI (1998) Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 158:1641–1647

    Article  PubMed  CAS  Google Scholar 

  28. Fitmaurice DA, Hobbs FD, Delaney BC et al (1998) Review of computerized decision support system for oral anticoagulation management. Br J Hematol 102:907–909

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Di Pasquale, G. et al. (2006). How Safe Is Anticoagulant Therapy in Older Patients and What Should Be the INR Target?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_21

Download citation

  • DOI: https://doi.org/10.1007/88-470-0371-7_21

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0370-5

  • Online ISBN: 978-88-470-0371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics